MedPath

Cinepazide

Generic Name
Cinepazide
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C22H31N3O5
CAS Number
23887-46-9
Unique Ingredient Identifier
67Y4P5C84X
Background

Cinepazide has been used in trials studying the treatment of Ischemic Stroke.

Indication

用于脑血管疾病,如脑动脉硬化,一过性脑缺血发作、脑血栓形成、脑栓塞、脑出血后遗症和脑外伤后遗症;心血管疾病,冠心病、心绞痛,如用于治疗心肌梗死,应配合有关药物综合治疗;外周血管疾病,下肢动脉血管粥样硬化病,血栓闭塞性脉管炎、动脉炎、雷诺现象等;糖尿病所致的周围血管病变及微循环障碍。

Associated Conditions
-
Associated Therapies
-

Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke

Not Applicable
Completed
Conditions
Stroke, Ischemic
Interventions
First Posted Date
2021-07-06
Last Posted Date
2021-07-06
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
1000
Registration Number
NCT04951232
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction

Phase 2
Conditions
Ischemic Stroke
Interventions
Drug: cinepazide
Drug: placebo
First Posted Date
2013-05-10
Last Posted Date
2013-05-10
Lead Sponsor
Xijing Hospital
Target Recruit Count
288
Registration Number
NCT01851759
Locations
🇨🇳

Xijing Hospital, Xi'an, Shaanxi, China

© Copyright 2025. All Rights Reserved by MedPath